PL443984A1 - Sposób zwiększania przenikalności substancji aktywnej przez barierę biologiczną - Google Patents

Sposób zwiększania przenikalności substancji aktywnej przez barierę biologiczną

Info

Publication number
PL443984A1
PL443984A1 PL443984A PL44398423A PL443984A1 PL 443984 A1 PL443984 A1 PL 443984A1 PL 443984 A PL443984 A PL 443984A PL 44398423 A PL44398423 A PL 44398423A PL 443984 A1 PL443984 A1 PL 443984A1
Authority
PL
Poland
Prior art keywords
active substance
biological barrier
permeability
increasing
magnetic field
Prior art date
Application number
PL443984A
Other languages
English (en)
Inventor
Paula Ossowicz-Rupniewska
Rafał Rakoczy
Anna Nowak
Maciej Konopacki
Marian Kordas
Łukasz Kucharski
Original Assignee
Zachodniopomorski Uniwersytet Technologiczny W Szczecinie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zachodniopomorski Uniwersytet Technologiczny W Szczecinie filed Critical Zachodniopomorski Uniwersytet Technologiczny W Szczecinie
Priority to PL443984A priority Critical patent/PL443984A1/pl
Publication of PL443984A1 publication Critical patent/PL443984A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/002—Magnetotherapy in combination with another treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/12—Magnetotherapy using variable magnetic fields obtained by mechanical movement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób zwiększania przenikalności substancji aktywnej (formulacji farmaceutycznej) przez barierę biologiczną, według wynalazku, zwłaszcza przez skórę, polegający na ekspozycji bariery biologicznej będącej w kontakcie z substancją aktywną na pole magnetyczne, który charakteryzuje się tym, że stosuje się wirujące pole magnetyczne o częstotliwości wirowania 50 Hz, indukcji magnetycznej 34 mT przez czas od 0,5 do 24 godzin.
PL443984A 2023-03-07 2023-03-07 Sposób zwiększania przenikalności substancji aktywnej przez barierę biologiczną PL443984A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL443984A PL443984A1 (pl) 2023-03-07 2023-03-07 Sposób zwiększania przenikalności substancji aktywnej przez barierę biologiczną

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL443984A PL443984A1 (pl) 2023-03-07 2023-03-07 Sposób zwiększania przenikalności substancji aktywnej przez barierę biologiczną

Publications (1)

Publication Number Publication Date
PL443984A1 true PL443984A1 (pl) 2024-09-09

Family

ID=92676931

Family Applications (1)

Application Number Title Priority Date Filing Date
PL443984A PL443984A1 (pl) 2023-03-07 2023-03-07 Sposób zwiększania przenikalności substancji aktywnej przez barierę biologiczną

Country Status (1)

Country Link
PL (1) PL443984A1 (pl)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011053984A1 (en) * 2009-11-02 2011-05-05 Pulse Therapeutics, Inc. Magnetomotive stator system and methods for wireless control of magnetic rotors
WO2019108536A1 (en) * 2017-11-29 2019-06-06 Pulse Therapeutics, Inc. Delivery of magnetic particles in conjunction with therapeutic and/or diagnostic agents
US20210370085A1 (en) * 2020-05-29 2021-12-02 Harvey Wayne Ko Electromagnetic method for in-vivo disruption of viral insults
CN114652515A (zh) * 2022-05-01 2022-06-24 付文军 多功能局部场调节装置

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011053984A1 (en) * 2009-11-02 2011-05-05 Pulse Therapeutics, Inc. Magnetomotive stator system and methods for wireless control of magnetic rotors
WO2019108536A1 (en) * 2017-11-29 2019-06-06 Pulse Therapeutics, Inc. Delivery of magnetic particles in conjunction with therapeutic and/or diagnostic agents
US20210370085A1 (en) * 2020-05-29 2021-12-02 Harvey Wayne Ko Electromagnetic method for in-vivo disruption of viral insults
CN114652515A (zh) * 2022-05-01 2022-06-24 付文军 多功能局部场调节装置

Similar Documents

Publication Publication Date Title
Del Pozo et al. The electricidal effect is active in an experimental model of Staphylococcus epidermidis chronic foreign body osteomyelitis
de Mesy Bentley et al. Chronic osteomyelitis with Staphylococcus aureus deformation in submicron canaliculi of osteocytes: a case report
Zhang et al. Improved antibacterial activity and biocompatibility on vancomycin-loaded TiO2 nanotubes: in vivo and in vitro studies
Dembélé et al. Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures
Horobin et al. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin‐coated surface
Kozin et al. Atypical Mycobacterium infections of the upper extremity
Wang et al. Epigallocatechin‑3‑gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metalloproteinase‑2
Shan et al. Surfactin inhibits the growth of Propionibacterium acnes by destroying the cell wall and membrane
EP3845247A4 (en) USE OF AN AMINO ACID NUTRIENT AND PHARMACEUTICAL COMPOSITION WITH AN AMINO ACID NUTRIENT
Gao et al. Salidroside alleviates cartilage degeneration through NF-κB pathway in osteoarthritis rats
Nasih Lembaga Fatwa Keagamaan di Indonesia (Telaah Atas Lembaga Majlis Tarjih dan Lajnah Bathsul Masail)
Ding et al. Electron spin polarization engineering in ferromagnetic bioheterojunction for sonotherapy of osteomyelitis
PH12021553102A1 (en) Methods of treating fabry disease in patients having renal impairment
Ghorbanizadeh et al. Antibacterial effects and cellular mechanisms of iron oxide magnetic nanoparticles coated by piroctone olamine against some cariogenic bacteria
Ercan et al. Inhibition of biofilms by non-thermal plasma treated novel solutions
Pan et al. Cleistanthin A inhibits the invasion and metastasis of human melanoma cells by inhibiting the expression of matrix metallopeptidase‑2 and‑9
Li et al. Effects of total alkaloids of Sophora alopecuroides on biofilm formation in Staphylococcus epidermidis
Wang et al. Trehalose delays postmenopausal osteoporosis by enhancing AKT/TFEB pathway‑dependent autophagy flow in rats
Hedke et al. Low-grade infection after a total knee arthroplasty caused by Actinomyces naeslundii
Duffy et al. A porcine model for the development and testing of preoperative skin preparations
Yao et al. Internal and surface-localized major surface proteases of Leishmania spp. and their differential release from promastigotes
Wang et al. Modulation of Ca2+ signals by epigallocatechin-3-gallate (EGCG) in cultured rat hippocampal neurons
Funk et al. Potent stimulation of blood flow in fingers of volunteers after local short‐term treatment with low‐frequency magnetic fields from a novel device
Osotprasit et al. Anti-Metastatic Effects of Plukenetia volubilis (Sacha Inchi) Husk Extract via EGFR and EMT Pathways and Other Antitumor Effects in Colon Cancer
Tayyar et al. Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237